Company / Operating Income
Verrica Pharmaceuticals Inc. Operating Income History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$65.9M
FY2025
5-year range
-$65.9M / -$21.3M
FY2021-FY2025
Trend
-0.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$21M to -$66M over the past 2 years.
Based on SEC 10-K filings.
-$66M in FY2025.
Declined from -$21M to -$66M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income decreased 0.2% year-over-year.
- Peak operating income was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$65.9M | -0.2% |
| FY2024 | -$65.8M | -208.8% |
| FY2023 | -$21.3M | +31.1% |
| FY2022 | -$30.9M | +23.1% |
| FY2021 | -$40.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026